2-(Propan-2-yl)cyclohexan-1-amine

Catalog No.: 
ACLJRD073
CAS No.: 
6850-64-2
Molecular Formula: 
C9H19N
Molecular Weight: 
141.26
2-(Propan-2-yl)cyclohexan-1-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$235.00InquiryInquiry
100mg95%$338.00InquiryInquiry
250mg95%$474.00InquiryInquiry
1g95%$942.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Propan-2-yl)cyclohexan-1-amine
IUPAC Name2-isopropylcyclohexan-1-amine
MDL No.MFCD16824860
Molecular FormulaC9H19N
Molecular Weight141.26
SMILESNC1C(C(C)C)CCCC1
InChI KeyIUUHHWALHWRYPY-UHFFFAOYSA-N
Synonym2-isopropylcyclohexan-1-amine;Cyclohexanamine, 2-(1-methylethyl)-;2-(propan-2-yl)cyclohexan-1-amine
CAS No.6850-64-2

Safety Data

Pictogram
FlammableCorrosive
Signal Word
Danger
Hazard Statement(s)
H226-H314
Precautionary Statement(s)
P210-P233-P240-P241-P242-P243-P260-P264-P280-P301+P330+P331-P303+P361+P353-P304+P340-P305+P351+P338-P310-P363-P370+P378-P403+P235-P405-P501

Synthetic Route by SureRoute

1. ACLJRD073 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACLJRD073 route product structure diagram
    ACLJRD0736850-64-2
Inquiry

2. ACLJRD073 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACLJRD073 route product structure diagram
    ACLJRD0736850-64-2
Inquiry

3. ACLJRD073 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLJRD073 route product structure diagram
    ACLJRD0736850-64-2
Inquiry

Comments (0)